MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder mainly characterized by amyloid-beta (Aβ) deposition and neurofibrillary tangles (NFTs). The abnormal enrichment of amyloid protein precursor (APP) leads to a high risk of AD. One of the plausible age-associated AD animal models, senescence-accelerated mouse prone 8 (SAMP8), have age-related learning and memory deficits. We found APP protein significantly increased in the hippocampus of aged SAMP8 mice. The 20 to 25 nucleotide (nt) tiny regulators, known as micro ribonucleic acids (miRNAs), have been found to play crucial roles in neurodegenerative diseases. Here, we examined the post-transcriptional regulation mechanism of APP mediated by micro ribonucleic acids and found that miR-16 was one of the post-transcriptional regulators of APP in SAMP8 mice. Overexpression of miR-16, both in vitro and in vivo, led to reduced APP protein expression. Furthermore, miR-16 and APP displayed complementary expression patterns in SAMP8 mice and BALb/c mice embryos. Taken together, these findings demonstrate that APP is a target of miR-16 and the abnormally low expression of miR-16 could potentially lead to APP protein accumulation in AD mice.

Introduction

Alzheimer's disease (AD) is a devastating neurodegenerative disorder that affects elderly people worldwide. It is the most common form of dementia (Bertram and Tanzi, 2008, Hardy and Selkoe, 2002, Harris et al., 2003). The 2 hallmark histopathological changes in AD patients are amyloid plaques and neurofibrillary tangles (NFTs) (Haass and Selkoe, 2007). The amyloid-β peptide (Aβ), an inaccurately cleaved product of the amyloid precursor protein (APP), contributes to the core element of plaques, and the hyperphosphorylated microtubule binding protein tau makes up the core of the tangles (Annaert and De Strooper, 2002, Vassar and Citron, 2000).

Endogenous mature micro ribonucleic acids (miRNAs) of 20 to 25 nt have been implicated as critical regulators in the expression and function of eukaryotic genomes (Ambros, 2001, Ambros, 2004, Bicker and Schratt, 2008). Translational repression or degradation of messenger ribonucleic acid (mRNA) occurs when miRNAs bind to the ribonucleic acid (RNA)-induced silencing complex (RISC) (Bartel, 2004, Gregory et al., 2005, Kim, 2005). One miRNA could potentially regulate large numbers of target genes synchronously, which implies that miRNAs may be important sculptors of transcriptional networks (Bartel and Chen, 2004). As such, they are attractive candidates for regulating development (Cao et al., 2007, Gangaraju and Lin, 2009, Makeyev et al., 2007, Shibata et al., 2008) and pathological changes (Hebert et al., 2008, Lee et al., 2008, Merritt et al., 2008, Zhang et al., 2009). miRNAs are also implicated in cell fate determination (Fazi and Nervi, 2008, Gangaraju and Lin, 2009), apoptosis (Dogini et al., 2008), proliferation (Grady et al., 2008), and stress (Pothof et al., 2009). Recent studies of mammals have suggested a role for miRNAs in neurodegenerative diseases and neuroprotection (Boissonneault et al., 2009, Hebert et al., 2008, Singh, 2007). miR-133b is lost in the midbrain of patients with Parkinson's disease but relatively highly expressed at the tissue level under normal conditions (Kim et al., 2007). Some miRNAs such as miR-9 and miR-125b show high expression in AD (Lukiw, 2007). BACE1/β-secretase, observed in patients with sporadic AD, cleaves APP into Aβ, and the miR-29a/b-1 cluster can regulate BACE1 expression (Hebert et al., 2008).

One of the senescence-accelerated mouse (SAM) strains, SAM prone 8 (SAMP8), shows aging features (Takeda et al., 1991). It has been demonstrated that SAMP8 mice have deficits in age-related learning and memory and could be a plausible model to investigate the fundamental mechanism of early-onset AD. APP accumulation occurs around the hippocampal area with increased age, and plaques also appear when the SAMP8 mice acquire deficits but not in normal aging SAMR1 mice (Flood and Morley, 1992, Flood and Morley, 1993, Miyamoto et al., 1986, Morley, 2002).

Here, we chose the SAMP8 strain as a mouse model and the SAMR1 strain as a control to explore AD-associated pathogenesis and the links between miRNAs and AD. Because abnormal APP enrichment in the brain could actually increase the risk of AD (Theuns and Van Broeckhoven, 2000) and is known to be 1 of the characteristic features of AD (Annaert and De Strooper, 2002), we addressed the posttranscriptional regulation of APP.